1-161629848-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001244753.2(FCGR3B):āc.249C>Gā(p.Asp83Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000054 in 1,426,558 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001244753.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FCGR3B | NM_001244753.2 | c.249C>G | p.Asp83Glu | missense_variant | 3/5 | ENST00000650385.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FCGR3B | ENST00000650385.1 | c.249C>G | p.Asp83Glu | missense_variant | 3/5 | NM_001244753.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000459 AC: 36AN: 78446Hom.: 6 Cov.: 10
GnomAD3 exomes AF: 0.000101 AC: 23AN: 227300Hom.: 4 AF XY: 0.0000567 AC XY: 7AN XY: 123560
GnomAD4 exome AF: 0.0000304 AC: 41AN: 1348056Hom.: 4 Cov.: 30 AF XY: 0.0000328 AC XY: 22AN XY: 671404
GnomAD4 genome AF: 0.000459 AC: 36AN: 78502Hom.: 6 Cov.: 10 AF XY: 0.000434 AC XY: 16AN XY: 36894
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2023 | The c.249C>G (p.D83E) alteration is located in exon 4 (coding exon 3) of the FCGR3B gene. This alteration results from a C to G substitution at nucleotide position 249, causing the aspartic acid (D) at amino acid position 83 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at